Management Strategy of Polypoid Lesions of the Gallbladder
1 other identifier
observational
672
1 country
1
Brief Summary
We retrospectively review a single-center cohort of gallbladder polyps from January 2015 to May 2020. Univariate and multivariable analyses were performed to extract potential risky factors of neoplastic polyps. Also, a comparison was conducted between laparoscopic cholecystectomy (LC) and laparoscopic polypectomy (LP) to explore factors affecting surgeons' decision on LC or LP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedFirst Submitted
Initial submission to the registry
February 17, 2021
CompletedFirst Posted
Study publicly available on registry
February 21, 2021
CompletedFebruary 21, 2021
January 1, 2015
5.4 years
February 17, 2021
February 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pathological diagnosis of polyps
Pathological diagnosis of polyps
Up to two weeks after surgery
Study Arms (2)
Non-neoplastic group
Gallbladder polyps with pathological diagnosis of cholesterol polyps or inflammatory polyps are classified into "Non-neoplastic group".
Neoplastic group
Gallbladder polyps pathologically diagnosed as adenocarcinoma, adenoma, adenomyosis, or other malignancies are classified into "Neoplastic group".
Interventions
Eligibility Criteria
surgical candidates of laparoscopic cholecystectomy or laparoscopic polypectomy.
You may qualify if:
- Surgical indications for LC included polyp diameter over 10 millimeters, or polyps accompanied by GB stones, or consideration of neoplastic polyps. Surgical indications for GB-preserving surgery included GB with normal emptying function and polyp diameter smaller than 10 millimeters, or consideration of benign non-neoplastic polyps, or asymptomatic polyps.
You may not qualify if:
- Those do not fit for laparoscopic surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking Union Medical College Hospital
Beijing, China
Study Officials
- STUDY DIRECTOR
Qiang Qu, Doctor
Peking Union Medical College Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 17, 2021
First Posted
February 21, 2021
Study Start
January 1, 2015
Primary Completion
May 31, 2020
Study Completion
December 31, 2020
Last Updated
February 21, 2021
Record last verified: 2015-01